Literature DB >> 20031471

Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.

Samy Slimani1, Amina Abdessemed, Assia Haddouche, Aicha Ladjouze-Rezig.   

Abstract

A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided. Pamidronate (2mg/kg/year) produced dramatic improvement of pain and function within 2 months and calcinosis had completely resolved by 2 years. No new calcifications have been noted with a 5-year follow-up. Copyright 2009 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20031471     DOI： 10.1016/j.jbspin.2009.04.011

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


  11 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 2.  Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors:  Emily G Farrow; Erik A Imel; Kenneth E White
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-10       Impact factor: 4.098

Review 3.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

4.  Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.

Authors:  Jared Martillotti; Douglas Moote; Lawrence Zemel
Journal:  Pediatr Radiol       Date:  2013-07-10

5.  Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.

Authors:  Hiroko Mori; Yosuke Okada; Kunihiro Yamaoka; Kazuyoshi Saito; Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2011-06-28       Impact factor: 2.626

Review 6.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

7.  Treatment of calcinosis associated with adult and juvenile dermatomyositis using topical sodium thiosulfate via fractionated CO2 laser treatment.

Authors:  Misty G Eleryan; Olabola Awosika; Sophia Akhiyat; Azam Qureshi; Monica Rengifo-Pardo; Rodolfo Curiel; Lisa G Rider; Alison Ehrlich
Journal:  Clin Exp Rheumatol       Date:  2019-11-18       Impact factor: 4.473

8.  Rituximab-induced regression of CREST-related calcinosis.

Authors:  Dayane Raquel de Paula; Fabiane Barbero Klem; Pedro Gabriel Lorencetti; Carolina Muller; Valderilio Feijó Azevedo
Journal:  Clin Rheumatol       Date:  2012-11-21       Impact factor: 2.980

9.  Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.

Authors:  Isha Saini; Mani Kalaivani; Sushil Kumar Kabra
Journal:  Rheumatol Int       Date:  2016-03-23       Impact factor: 2.631

10.  Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis.

Authors:  Takayuki Wakabayashi; Noriko Sasaki; Naofumi Chinen; Yasuo Suzuki
Journal:  Case Rep Rheumatol       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.